Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer

NCT00114816 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: capecitabine
DRUG: docetaxel

Sponsor

Finnish Breast Cancer Group

Collaborators

[object Object]
[object Object]
[object Object]